Netherlands· NL-75a0f10941d4
Doxylamine Geiser Pharma 12,5 mg poeder voor oraal gebruik
A doxylamine product containing doxylaminewaterstofsuccinaat, registered in Netherlands by Geiser Pharma S.L.. The same ATC class is registered in 5 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Doxylamine is registered in 5 of 19 countries.
Countries holding a registration under ATC R06AA09 (doxylamine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 4 of them publish a price we can compare per daily dose
Doxylamine · ATC R06AA09
5 / 19 countries
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DOXYLAMINEWATERSTOFSUCCINAAT
- Manufacturer
- Geiser Pharma S.L.
- Country
- Netherlands (NL)
- ATC code
- R06AA09
- ATC class
- Doxylamine
- Defined daily dose
- 25 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id130094
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
318 interactions on record for doxylamine.
Graded by severity as the source publishes them — 19 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Doxylamine · interactions on record
318 records
- 19 severe
- 298 moderate
- 1 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- LinezolidJ01XX08severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Doxylamine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandDoxypatGeiser Pharma S.L.
- United StatesBasic Care Sleep AidAmazon.com Services LLC
- SpainDORMIDINA DOXILAMINA 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULAEsteve Pharmaceuticals S.A.
- FranceDONORMYL 15 mg, comprimé effervescent sécableUPSA
- GermanyDolginox SchlaftropfenDr. Theiss Naturwaren Gmbh
- FinlandDormixOrion Corporation
- NorwayDormidina doxilaminaEsteve Pharmaceuticals S.A
- BelgiumNavalit 10 mg - 10 mgEFFIK Benelux
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Hoggar Night
- Cyprus · Hoggar Night
- Germany · Dolginox Schlaftropfen, Doxylamin Dexcel
- Spain · Dormidina, Dormigen
- Finland · Dormix
- France · Donormyl, Doxylamine Arrow Conseil
- Greece · Hoggar Night
- Croatia · Hoggar
- Hungary · Hoggar
- Malta · Doxylamine Krka, Normodorm
- Norway · Zonat
- Poland · Benosen, Doksylamina Geiser
- Portugal · Dormidina, Hoggar
- Slovenia · Noctiben Mea
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5be3a63-5e1e-4e5b-87a2-f2f76ab6210e GET /v1/drugs/b5be3a63-5e1e-4e5b-87a2-f2f76ab6210e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor oraal gebruik",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h130094_smpc.pdf",
"strength": null,
"atc_label": "Doxylamine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130094",
"excipients": [
"AARDBEIENSMAAKSTOF",
"ACESULFAAM KALIUM (E 950)",
"ARABISCHE GOM (E 414)",
"ASPARTAAM (E 951)",
"ASPARTAAM (E 951)",
"CALCIUMCARBONAAT (E 170)",
"CITROENZUUR 0-WATER (E 330)",
"GLYCEROLTRIACETAAT (E 1518)",
"MALTODEXTRINE",
"MALTODEXTRINE",
"MANNITOL (D-) (E 421)",
"MASKEERSMAAKSTOF",
"NATRIUMDIWATERSTOFCITRAAT (E 331)",
"NATRIUMWATERSTOFCARBONAAT (E 500 (II))",
"NATRIUMZETMEELGLYCOLAAT",
"PROPYLEENGLYCOL (E 1520)",
"SACCHAROSE",
"SILICIUMDIOXIDE (E 551)"
],
"substances": [
"DOXYLAMINEWATERSTOFSUCCINAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130094.pdf",
"authorised_at": "2023/10/23",
"procedure_number": "DE/H/7537/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "130094",
"additional_monitoring": "N"
}See everything about doxylamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.